KOSDAQ · Healthcare · ₩61B
₩6760.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 0.0% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“치료제 시험 결과와 새 계약이 다음 성장을 결정할 시점이에요.”
In the company's words · 2026 2분기 filing